Literature DB >> 11528510

Familial Mediterranean fever: prevalence, penetrance and genetic drift.

R Gershoni-Baruch1, M Shinawi, K Leah, K Badarnah, R Brik.   

Abstract

FMF is widely distributed in populations inhabiting the Mediterranean basin. It is mainly attributed to five founder mutations (M680I, M694V, M694I, V726A, E148Q) in the MEFV gene. The frequencies and distribution of these mutations in 146 FMF patients, of Arab and Jewish descent, were compared to that observed in 1173 healthy individuals of pertinent ethnic groups. Five mutations accounted for 91% of FMF chromosomes in our patients. Mutation M694V, predominant in North African Jews, was observed in all patients other than Ashkenazi Jews; mutation V726A was prevalent among all patients other than North African Jews; mutations M694I and M680I were mainly confined to Arab patients. Overall carrier rates, for four mutations (M680I, M694V, V726A, E148Q), were extremely high in our healthy cohort composed of Ashkenazi (n=407); Moroccan (n=243); Iraqi Jews (n=205); and Muslim Arabs (n=318); calculated at 1 : 4.5; 1 : 4.7; 1 : 3.5 and 1 : 4.3 respectively. The V726A allele prevalent among Ashkenazi and Iraqi Jews and Muslim Arabs (carrier rates: 7.4, 12.8 and 7.3%, respectively) was not found among Moroccan Jews. The M694V allele detected among Moroccan and Iraqi Jews and Muslim Arabs (carrier rates 11.1, 2.9 and 0.6%, respectively) was not observed among Ashkenazim. The overall frequency of mutations V726A and E148Q in Ashkenazim, Iraqi Jews and Arabs indicates that the bulk of individuals that comply with the genetic definition of FMF remain asymptomatic.

Entities:  

Mesh:

Year:  2001        PMID: 11528510     DOI: 10.1038/sj.ejhg.5200672

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  37 in total

1.  The phenotype-genotype correlations of FMF patients: a single center study.

Authors:  Onur Sakallioglu; Faysal Gok; Suleyman Kalman; Davut Gul; Erdal Gokcay
Journal:  Rheumatol Int       Date:  2005-09-25       Impact factor: 2.631

2.  Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever.

Authors:  D O Tchernitchko; M Gérard-Blanluet; M Legendre; C Cazeneuve; G Grateau; S Amselem
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 3.  Recurrent febrile syndromes: what a rheumatologist needs to know.

Authors:  Hal M Hoffman; Anna Simon
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

4.  Establishing hospital admission criteria of pediatric Henoch-Schonlein purpura.

Authors:  Kamal Masarweh; Yoseph Horovitz; Avi Avital; Ronen Spiegel
Journal:  Rheumatol Int       Date:  2014-02-23       Impact factor: 2.631

Review 5.  An Update on Autoinflammatory Diseases: Inflammasomopathies.

Authors:  Cassandra R Harapas; Annemarie Steiner; Sophia Davidson; Seth L Masters
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

6.  Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis.

Authors:  M Bonyadi; Z Shaghaghi; M Haghi; S Dastgiri
Journal:  Eur J Pediatr       Date:  2012-10-05       Impact factor: 3.183

Review 7.  Autoinflammatory diseases in childhood, part 1: monogenic syndromes.

Authors:  María Navallas; Emilio J Inarejos Clemente; Estíbaliz Iglesias; Mónica Rebollo-Polo; Faizah Mohd Zaki; Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2020-02-17

Review 8.  Familial Mediterranean fever.

Authors:  Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2003-06-27       Impact factor: 3.714

9.  MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations.

Authors:  Ayman el-Garf; Samia Salah; Iman Iskander; Hala Salah; Sherif Naseh Amin
Journal:  Rheumatol Int       Date:  2009-09-24       Impact factor: 2.631

10.  [Recurrent bouts of fever accompanied by abdominal pain and emesis].

Authors:  K Blassneck; G Nusko; J Benninger; E G Hahn; I A Harsch
Journal:  Internist (Berl)       Date:  2004-10       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.